This HTML5 document contains 121 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35227504
rdf:type
wikibase:Item
schema:description
vitenskapelig artikkel 2014年論文 vedecký článok 2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած научни чланак scienca artikolo artigo científico 2014年论文 2014年論文 مقالة علمية 2014年の論文 мақолаи илмӣ artigo científico (publicado na 2014) سائنسی مضمون naučni članak wissenschaftlicher Artikel artikull shkencor 2014年论文 mokslinis straipsnis наукова стаття, опублікована в липні 2014 article scientifique (publié 2014) artículu científicu espublizáu en 2014 2014年论文 2014年論文 articol științific мақолаи илмӣ artykuł naukowy tieteellinen artikkeli bilimsel makale 2014年論文 научна статия 2014年论文 article científic ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ wetenschappelijk artikel 2014년 논문 מאמר מדעי vetenskaplig artikel bài báo khoa học مقالهٔ علمی artikulong pang-agham บทความทางวิทยาศาสตร์ article scientific επιστημονικό άρθρο vitskapeleg artikkel 2014 nî lūn-bûn vědecký článek научни чланак artigo científico (publicado na 2014) სამეცნიერო სტატია teaduslik artikkel 2014年论文 2014年論文 tudományos cikk scientific article videnskabelig artikel (udgivet 2014) научная статья 2014年论文 articolo scientifico 2014 թվականի հուլիսին հրատարակված գիտական հոդված artículo científico publicado en 2014
p:P577
wds:Q35227504-D369E90F-6FB4-45F6-A0D0-41808410260D
wdt:P577
2014-07-22T00:00:00Z
p:P407
wds:Q35227504-EB348DD1-43A9-4C52-931A-F4C395A42692
wdt:P407
wd:Q1860
p:P2093
wds:Q35227504-4F62E013-6A6C-48DB-A941-7613BFE68DEE wds:Q35227504-3A6B9C53-9FF6-4530-A850-DDC340E4A7FF wds:Q35227504-4AC90EFD-9F72-4671-A2F0-8D9880903940 wds:Q35227504-3675474C-AEEF-4210-A988-61AC78214EFF wds:Q35227504-EDD8DC1E-3B9D-464D-BB8C-4844EF5AE379 wds:Q35227504-F3CA2752-2580-421B-A302-78EB25D5065D wds:Q35227504-EB1558CC-33F8-4867-84A4-61BBECF1B03D wds:Q35227504-C21981B8-AACA-4A82-95B4-999C97702DE3 wds:Q35227504-AC3A8E92-9878-43FA-9CC4-DA1FC0FB2ABC wds:Q35227504-AA0020AA-3D29-4B2F-96A8-1C74B9442CDF wds:Q35227504-8949DA5B-3573-4C4E-B38D-A28076B81C19
wdt:P2093
Irene Kührer Brigitte Wolf Ahmed Ba-Ssalamah Sonja Kappel Martina Mittlböck Johannes Zacherl Ursula Pluschnig Michael Hejna Ronald Zwrtek Daniela Kandioler Fritz Wrba
rdfs:label
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
skos:prefLabel
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
schema:name
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
p:P50
wds:Q35227504-547C3DED-E8A5-4012-8EC1-D824149A28CE
wdt:P50
wd:Q40796582
p:P1476
wds:Q35227504-EA5A5D57-F02F-4C12-B107-8BA0E28D4FEB
wdt:P1476
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study
p:P304
wds:Q35227504-B1C74F5F-B1A1-4A2A-89E2-2A4876062694
wdt:P304
2280-2286
p:P31
wds:Q35227504-F4CB43F1-30B7-485C-B941-71F1E1ECD52E
wdt:P31
wd:Q13442814
p:P921
wds:Q35227504-284AFC13-218F-47F1-9808-35E9B71FFE44 wds:Q35227504-2B0BF42D-C194-46FB-BE4D-2694FDE390BC
wdt:P921
wd:Q864574 wd:Q372701
p:P698
wds:Q35227504-8B68FD71-7310-4A3A-BDD2-554702313303
wdtn:P698
n11:25135238
wdt:P698
25135238
p:P1433
wds:Q35227504-28187B4F-DEE3-4046-8C13-80FBA160A4E5
wdt:P1433
wd:Q2795598
p:P433
wds:Q35227504-FC2F3DFC-836B-450B-9436-D182256C58D3
p:P478
wds:Q35227504-6473596F-42CA-41C8-84CB-F3C7115ADF35
wdt:P433
5
wdt:P478
148
p:P356
wds:Q35227504-E8C94CE8-ADA7-44CC-B639-A5F17F4999C1
wdtn:P356
n12:J.JTCVS.2014.06.079
wdt:P356
10.1016/J.JTCVS.2014.06.079